Table 2.
The changes of measured parameters of IC/BPS from baseline to post-PRP treatment in 19 patients
| Variable | Baseline | After PRP | P-value |
|---|---|---|---|
| OSS | 21.00 ± 8.37 | 14.70 ± 6.37 | 0.009 |
| ICSI | 11.50 ± 4.86 | 7.95 ± 3.36 | 0.006 |
| ICPI | 9.47 ± 4.17 | 6.58 ± 3.50 | 0.015 |
| VAS | 4.05 ± 3.27 | 1.95 ± 2.34 | 0.003 |
| Functional capacity | 217.6 ± 116.9 | 290.3 ± 124.0 | 0.001 |
| Qmax (mL/sec) in UFM | 9.55 ± 4.59 | 20.20 ± 6.96 | 0.000 |
| PVR (mL) in UFM | 37.3 ± 92.1 | 11.8 ± 21.1 | 0.395 |
| VUDS parameters | |||
| FSF (mL) | 138.0 ± 65.5 | 151.0 ± 43.0 | 0.444 |
| FS (mL) | 207.0 ± 89.2 | 220.0 ± 48.4 | 0.591 |
| CBC (mL) | 271.0 ± 97.2 | 251.0 ± 144 0 | 0.719 |
| Pdet (cm H2O) | 15.0 ± 7.1 | 17.6 ± 6.8 | 0.400 |
| Qmax (mL/sec) | 10.2 ± 7.1 | 11.8 ± 5.9 | 0.551 |
| Volume voided (mL) | 194 ± 124 | 246 ± 121 | 0.191 |
| PVR (mL) | 86.4 ± 150.0 | 26.4 ± 31.0 | 0.240 |
| Positive KCl test | 16/19 (84.2) | 6/19 (31.6) | 0.001 |
| Glomerulation | 1.84 ± 1.21 | - | - |
| Maximum capacity | 579.0 ± 212.3 | - | - |
| GRA | - | 1.11 ± 0.66 |
Values are presented as mean±standard deviation or number (%).
IC/BPS, interstitial cystitis/bladder pain syndrome; PRP, platelet-rich plasma; OSS, O’Leary-Sant symptom score; ICSI, interstitial cystitis symptom index; ICPI, interstitial cystitis problem index; VAS, visual analogue scale; UFM, uroflowmetry; Qmax, maximum flow rate; PVR, postvoid residual; VUDS, videourodynamic study; FSF, first sensation of filling; FS, fullness sensation; CBC, cystometric bladder capacity; Pdet, detrusor pressure; KCl, potassium chloride; GRA, global response assessment.